Gastrointestinal Endoscopy
Volume 70, Issue 6 , Pages 1072-1078.e1 , December 2009

Use of a new jumbo forceps improves tissue acquisition of Barrett's esophagus surveillance biopsies

  • Sri Komanduri, MD, MS

      Affiliations

    • Corresponding Author InformationReprint requests: Srinadh Komanduri, MD, MS, Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, 676 North St. Claire Street, #14-003, Chicago, IL 60611.
    • ,
  • Garth Swanson, MD
    • ,
  • Laurie Keefer, PhD
    • ,
  • Shriram Jakate, MD, FRCPath

Received 4 January 2009 ,Accepted 10 April 2009.

References 

  1. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142–146
  2. Johansson J, Hakansson HO, Mellblom L, et al. Risk factors for Barrett's oesophagus: a population-based approach. Scand J Gastroenterol. 2007;42:148–156
  3. Campos GM, DeMeester SR, Peters JH, et al. Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg. 2001;136:1267–1273
  4. Rastogi A, Puli S, El-Serag HB, et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008;67:394–398
  5. Souza RF, Krishnan K, Spechler SJ. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am J Physiol Gastrointest Liver Physiol. 2008;295:G211–G218
  6. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology. 2000;119:333–338
  7. Peters FP, Curvers WL, Rosmolen WD, et al. Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error. Dis Esophagus. 2008;21:475–479
  8. Zhang HY, Spechler SJ, Souza RF. Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett. 2009;275:170–177
  9. Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2000;119:1126–1132
  10. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol. 2008;103:788–797
  11. Abela JE, Going JJ, Mackenzie JF, et al. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol. 2008;103:850–855
  12. Corley DA, Kubo A, DeBoer J, et al. Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses. Gastrointest Endosc. 2009;69:1004–1010
  13. Harrison R, Perry I, Haddadin W, et al. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007;102:1154–1161
  14. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg. 1996;224:66–71
  15. Falk GW, Rice TW, Goldblum JR, et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc. 1999;49:170–176
  16. Woods KL, Anand BS, Cole RA, et al. Influence of endoscopic biopsy forceps characteristics on tissue specimens: results of a prospective randomized study. Gastrointest Endosc. 1999;49:177–183
  17. Elmunzer BJ, Higgins PD, Kwon YM, et al. Jumbo forceps are superior to standard large-capacity forceps in obtaining diagnostically adequate inflammatory bowel disease surveillance biopsy specimens. Gastrointest Endosc. 2008;68:273–278quiz 334, 336
  18. Gopal DV, Lieberman DA, Magaret N, et al. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci. 2003;48:1537–1541
  19. Musana AK, Resnick JM, Torbey CF, et al. Barrett's esophagus: incidence and prevalence estimates in a rural Mid-Western population. Am J Gastroenterol. 2008;103:516–524

 DISCLOSURE: The forceps for this investigation were provided by the Boston Scientific Corporation. The following author disclosed financial relationships relevant to this publication: S. Komanduri: Speaker for Boston Scientific; consultant for Tap Pharmaceuticals. All other authors disclosed no financial relationships relevant to this publication.

 If you would like to chat with an author of this article, you may contact him at sri_komanduri@yahoo.com.

PII: S0016-5107(09)01728-3

doi: 10.1016/j.gie.2009.04.009

Gastrointestinal Endoscopy
Volume 70, Issue 6 , Pages 1072-1078.e1 , December 2009

Article Tools

* Image Usage & Resolution